Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Rozhan Omar is a specialist of Oncology and Clinical Hematology at Hiwa Cancer Center. She received her Medical Degree from the University of Sulaimanyah in 2008. She completed her High Diploma Degree in Oncology and Clinical Hematology in 2016. Her main interests are Breast and Gynecological cancers. She is a Member of the American Society of Clinical Oncology and the European Society of Medical Oncology.
Abstract Background: Breast cancer affects one in every eight women in the Unites States and one in nineteen women locally. More than three quarters of patients are currently cured with modern therapy; this fact has been reproducible at our Hiwa Cancer Center, the only tertiary care oncology center in Sulaymaniyah, a city of two million population in Kurdistan. Evaluation of patients properly is the cornerstone upon which the rest of the management paradigm is based. Discrepancy in clinical, imaging and histological outcome in many patients has led us to consider this comparative study between what we perceive clinically, find radiologically and deliver from the histopathology department as the final and ultimate outcome. Undoubtedly decision making in the early management of this common cancer depends on the interaction between these diagnostic modalities. Patients & Methods: This is a retrospective and prospective study analyzing data obtained from clinical findings and imaging studies and comparing them with the histological report obtained from Shorsh hospital histology department, a reputable and well-staffed department working as an integral part of a multidisciplinary arrangement between the cancer caring departments in the city. All breast cancer patients managed from the inception of the hospital in 2007 will be studied retrospectively. Every patient who will be managed from the beginning of this study until the deadline for the postgraduate study period will also be prospectively studied and personally followed up. Data obtained will be critically analyzed and correlation between these findings will be made. Results: The mean age at diagnosis was 46.6 years, the younger age diagnosed with breast cancer was 23 years; for oldest age it was 75 years. The highest number of patients was reported in the fourth decade constituting 40% of all the patients. Mean menopausal age was 50.6±3 years; author had 67% cases in the premenopausal age and 33% cases in the postmenopausal age. % performing imaging preoperatively were 66% mammography, 8.6 ultrasound, 4% MRI. Regarding he mean tumor size mammography was dependable for the age of 40 and above (p value 0.007), ultrasound was dependable for the age of <40 with a (p value0.001). Regarding the detection of the breast mass by both ultrasound and mammography was high with the rate of 95.5%, and the detection of the axillary LN b ultrasound was 95.5% and by mammography was 98.6%. Conclusion: Author concluded that 67% of our patients were premenopausal. Ultrasound and mammography have a very comparable detection rate of axillary LN and recognizing breast cancer. Both ultrasound and mammography give a very similar size to histopathology size of the tumor but in specific age group.